02.05.2024 - SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) - Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that it will report .